Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion center in Baghdad, Iraq from 2006-2009

Saudi Medical Journal

Volumn 32, Issue 10, 2011, Pages 1046-1050

  Ataallah, Turky M ^a   Hanan, Khaleel A ^a   Maysoun, Kadoori S ^a   Sadoon, Alaani A ^b  

^a MINISTRY OF HEALTH   (Iraq)

^b UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ENDEMIC DISEASE; FEMALE; HEALTH CENTER; HEPATITIS B; HEPATITIS C; HUMAN; INFORMATION PROCESSING; IRAQ; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; RURAL AREA; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; URBAN AREA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY;

BLOOD DONORS; BLOOD TRANSFUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; IRAQ; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 84857066585     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMWR). Recommendations and Reports: Public Health Service Inter-Agency. Guidelines for Screening Donors of Blood, Plasma, Organs, Tissues, and Semen for Evidence, April 19, 1991/40(RR-4);1-17; (Cited 2011 Jan 10; Access on January 2011). Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/00043883.htm
2. Atallah MT. Clinical and laboratory assessment of hepatitis B surface antigen healthy carriers [thesis]. University of Baghdad: College of Medicine; 1987.
3. Omer AR. Viral hepatitis among hemophilic and thalassemic patients. Iraq: Centers for Disease Control and Prevention; 2004.
4. Lavanchy D. Public health measures in the control of viral hepatitis: a World Health Organization perspective for the next millennium. J Gastroenterol Hepatol 2002; 17 Suppl: S452-S459.
5. André F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18 Suppl 1: S20-S22.
6. Jutavijittum P, Yousukh A, Samountry B, Samountry K, Ounavong A, Thammavong T, et al. Seroprevalence of hepatitis B and C virus infections among Lao blood donors. Southeast Asian J Trop Med Public Health 2007; 38: 674-679.
7. Pickering LK, Baker CJ, Long SS, McMillan JA, editors. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village (IL): American Academy of Pediatrics; 2006. p. 356.
8. World Health Organization. Hepatitis C WHO fact sheet No 164, 2000 b. [Cited on 2007 May 14; Accessed on March 2010]. Available from: www.who.int/mediacentre/factsheets/fs164/en/print.html
9. Rodenas JG, Bacasen LC, Que ER. The prevalence of HBsAg (+) and Anti HCV (+) among healthy blood donors at east avenue medical center, Quezon City. Philippine Journal of Gastroenterology 2006; 2: 64-70.